These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3037171)

  • 1. Renin-angiotensin system and renal circulation in clinical congestive heart failure.
    Dzau VJ
    Kidney Int Suppl; 1987 May; 20():S203-9. PubMed ID: 3037171
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue renin-angiotensin system in myocardial hypertrophy and failure.
    Dzau VJ
    Arch Intern Med; 1993 Apr; 153(8):937-42. PubMed ID: 8386920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiopathologic bases for the use of angiotensin converting enzyme inhibitors in congestive heart failure].
    Campa PP
    Cardiologia; 1986 Oct; 31(10):833-6. PubMed ID: 3028628
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in kidney function following heart failure treatment: focus on renin-angiotensin system blockade.
    Blankstein R; Bakris GL
    Heart Fail Clin; 2008 Oct; 4(4):425-38. PubMed ID: 18760754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperkalemia risk and treatment of heart failure.
    Segura J; Ruilope LM
    Heart Fail Clin; 2008 Oct; 4(4):455-64. PubMed ID: 18760757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive and maladaptive actions of angiotensin II in patients with severe congestive heart failure.
    Packer M
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):66-73. PubMed ID: 3037891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renin-angiotensin-aldosterone system and heart failure: therapeutic aspects].
    Castaigne A; Bénacéraff S
    Therapie; 1998; 53(3):285-9. PubMed ID: 9773128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of angiotensin converting enzyme inhibitors in heart failure: a clinician's guide to minimizing azotemia and diuretic-induced electrolyte imbalances.
    Weinberg MS
    Clin Ther; 1993; 15(1):3-17; discussion 2. PubMed ID: 8458051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Converting enzyme inhibition: implications for renal perfusion and function.
    Hollenberg NK
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():73-9. PubMed ID: 6183037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting enzyme inhibitors and renal function in cardiac failure.
    Robertson JI; Richards AM
    Kidney Int Suppl; 1987 May; 20():S216-9. PubMed ID: 3037172
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitors of the renin-angiotensin system.
    Brunner HR; Nussberger J; Waeber B
    Arzneimittelforschung; 1993 Feb; 43(2A):274-8. PubMed ID: 8498978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
    Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiology and treatment of congestive heart failure--recently advanced strategy for heart failure].
    Kitabatake A
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):9-18. PubMed ID: 7744373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological aspects of the renin-angiotensin system and peroral angiotensin converting enzyme inhibition.
    Aurell M
    Scand J Urol Nephrol Suppl; 1984; 79():9-12. PubMed ID: 6089324
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
    Sandmann S; Unger T
    Drugs; 2002; 62 Spec No 1():43-52. PubMed ID: 12036388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal hemodynamic changes in heart failure.
    Blankstein R; Bakris GL
    Heart Fail Clin; 2008 Oct; 4(4):411-23. PubMed ID: 18760753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and pharmacology of angiotensin converting enzyme inhibitors.
    Antonaccio MJ
    J Pharmacol; 1983; 14 Suppl 3():29-45. PubMed ID: 6323887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.